Drug Profile
Aspirin/lisinopril/lovastatin
Alternative Names: CardiaPill; CP-101; polypill-CardioPharmaLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator CardioPharma
- Class Carboxylic acids; Esters; Lactones; Salicylic acids; Small molecules
- Mechanism of Action ACE inhibitors; Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 modulators; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Cardiovascular-disorders in USA (PO, Capsule)